MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Eye, Ocular, Optometry, Ophthalmology, Vision Health Companies
KALA BIO, Inc. (NASDAQ: KALA)
Organization & Developments: KALA BIO
Parents
KALA BIO, Inc. (NASDAQ: KALA)
Children
* KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases.
*Company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases.
*MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Jumps
Finance & Acquisition: KALA BIO
Key People: KALA BIO